Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

July 30, 2007

About time to get rid of B&L management!

Analysis of: Bausch & Lomb likely to reject AMO takeover bid | www.osnsupersite.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Steve Rubinstein, OD, OptometristSteve Rubinstein, OD
Optometrist, Sound Shore Vision Care
Implications: Current management is not responsive to my needs as a practitioner, nor my patient's needs. Let someone else try to make a venerable name good again.

Analysis: Current management, including the CEO who has admitted to lying on his resume, has not helped B&L rebound from its current difficulties in either the contact lens solution industry, nor the contact lens industry.

The contact lens solution plant that was recently re certified by the FDA could have been done a year ago when the FDA first stated problems occurred there. It took an additional 6 months, and a second recall to get it correct.

The contact lenses are the same design as previous HEMA lenses, in a silicone hydrogel material that has been around for years. Why wasn't the design switch years ago before Vistakon and Ciba?

Management has been responding to market challenges instead of creating them for other companies.

B&L has been a name in the optics industry for  over 60 years. It has been decimated by  poor management in the B & L  sunglass division sold to Luxottica. B&L was the first company to come with a marketable soft contact lens, now it is a laggard. B&L had the best in soft lens solutions, and RGP solutions. Now it hasn't had anything new for years in either field.

Lets breath some new life into a stoodgy, poorly run company. Lets get a company that can make new markets instead of try to keep old ones.

Is there some reason that Mr. Zarella doesn't want an AMO takeover? Does it have to do with stock options, or golden parachutes?

Other Analyses of the Same Source Article:
Will Bausch & Lomb (BOL) Accept AMO's (EYE) Better Bid?
July 30, 2007, Author: GLG Expert Contributor

Report a Concern

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-09-06T13:45:16.553